NYSE: FSK

FS KKR Capital Corp

CIK 0001422183

Mega by assets Assets $12.0B as of Nov 1, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (OGN 10-Q) is open in full — no account needed.

10-Q Filed Nov 5, 2026 · Period ending Sep 30, 2026

Summary not yet generated.

8-K Filed Nov 5, 2026 · Period ending Nov 5, 2026

Summary not yet generated.

Partner

Trade FSK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Oct 8, 2026 · Period ending Oct 7, 2026

Summary not yet generated.

8-K Filed Aug 20, 2026 · Period ending Aug 20, 2026

Summary not yet generated.

8-K Filed Aug 13, 2026 · Period ending Aug 13, 2026

FSK posts investor presentations to website under Regulation FD

1 material change detected. Sign up free to read the summary.

8-K Filed Aug 6, 2026 · Period ending Aug 6, 2026

Summary not yet generated.

10-Q Filed Aug 6, 2026 · Period ending Jun 30, 2026 Red flag

FSK net loss narrows 84% to -$34.0M as portfolio shrinks; four lawsuits filed

4 material changes detected. Sign up free to read the summary.

8-K Filed Jul 9, 2026 · Period ending Jul 9, 2026

Summary not yet generated.

8-K Filed Jun 29, 2026 · Period ending Jun 29, 2026

Summary not yet generated.

8-K Filed Jun 18, 2026 · Period ending Jun 18, 2026

Summary not yet generated.

8-K Filed Jun 8, 2026 · Period ending Jun 8, 2026

Summary not yet generated.

8-K Filed Jun 3, 2026 · Period ending Jun 1, 2026

Summary not yet generated.

10-Q Filed May 11, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K Filed Feb 25, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Nov 5, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed Aug 6, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-K Filed Feb 26, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

10-K/A Filed Apr 30, 2021 · Period ending Dec 31, 2020

Summary not yet generated.

424B3 Filed Mar 1, 2021

Summary not yet generated.

Latest financial statements

From 10-Q filed Nov 5, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Statements of Operations (Unaudited)

Description Three months ended September 30, 2026 Three months ended September 30, 2025 Nine months ended September 30, 2026 Nine months ended September 30, 2025
Investment income
From non-controlled/unaffiliated investments:
Interest income 152 217 495 658
Paid-in-kind interest income 10 24 24 55
Fee income 2 4 8 27
Dividend and other income — 6 11 30
From non-controlled/affiliated investments:
Interest income 3 7 6 23
Paid-in-kind interest income 14 15 39 51
Fee income 2 — 2 3
Dividend and other income 28 5 30 20
From controlled/affiliated investments:
Interest income 5 7 20 35
Paid-in-kind interest income 22 15 63 63
Fee income — — 1 —
Dividend and other income 56 73 189 206
Total investment income 294 373 888 1,171
Operating expenses
Management fees 42 51 134 156
Subordinated income incentive fees 23 33 71 108
Administrative services expenses 3 3 8 8
Accounting and administrative fees 1 1 3 3
Interest expense 99 116 305 354
Other general and administrative expenses 9 6 22 19
Total operating expenses 177 210 543 648
Subordinated income incentive fee waiver (12) — (23) —
Net expenses 165 210 520 648
Net investment income before taxes 129 163 368 523
Excise taxes 2 4 2 4
Net investment income 127 159 366 519
Realized and unrealized gain/loss
Net realized gain (loss) on investments:
Non-controlled/unaffiliated investments (133) (25) (179) (131)
Non-controlled/affiliated investments — (10) (170) (2)
Controlled/affiliated investments 7 (18) (49) (73)
Net realized gain (loss) on foreign currency forward contracts (3) — (7) (3)
Net realized gain (loss) on foreign currency (1) (20) (10) (25)
Net change in unrealized appreciation (depreciation) on investments:
Non-controlled/unaffiliated investments 160 (47) (126) 69
Non-controlled/affiliated investments (13) 6 82 (76)
Controlled/affiliated investments (77) 141 (341) (62)
Net change in unrealized appreciation (depreciation) on foreign currency forward contracts 3 3 11 (17)
Net change in unrealized gain (loss) on foreign currency 3 25 23 (60)
Total net realized and unrealized gain (loss) (54) 55 (766) (380)
Provision for taxes on investments — — — (11)
Realized loss on extinguishment of debt — — (2) (3)
Net increase (decrease) in net assets resulting from operations 73 214 (402) 125
Distributions to preferred stockholders (2) — (2) —
Net increase (decrease) in net assets resulting from operations applicable to common stockholders 71 214 (404) 125

Consolidated Balance Sheets (Unaudited)

Description September 30, 2026 (Unaudited) December 31, 2025
Assets
Investments, at fair value
Non-controlled/unaffiliated investments (amortized cost—$7,132 and $8,406, respectively) 6,765 8,164
Non-controlled/affiliated investments (amortized cost—$865 and $929, respectively) 872 855
Controlled/affiliated investments (amortized cost—$4,426 and $4,406, respectively) 3,669 3,990
Total investments, at fair value (amortized cost—$12,423 and $13,741, respectively) 11,306 13,009
Cash and cash equivalents 102 181
Restricted cash 61 —
Foreign currency, at fair value (cost—$9 and $27, respectively) 9 27
Receivable for investments sold and repaid 106 313
Income receivable 72 98
Unrealized appreciation on foreign currency forward contracts 3 —
Deferred financing costs 29 32
Prepaid expenses and other assets 7 69
Total assets 11,695 13,729
Liabilities
Payable for investments purchased 1 8
Debt (net of deferred financing costs and discount of $46 and $45, respectively) 6,231 7,634
Unrealized depreciation on foreign currency forward contracts 2 10
Stockholder distributions payable 121 —
Management fees payable 42 50
Subordinated income incentive fees payable 12 28
Administrative services expense payable 4 1
Interest payable 54 77
Other accrued expenses and liabilities 79 72
Total liabilities 6,546 7,880
Commitments and contingencies (Note 10)
Preferred stock, $0.001 par value per share, 50,000,000 shares authorized, respectively; 6,000,000 and 0 Cumulative Convertible Perpetual Preferred Stock, Series A shares, $0.001 par value per share, $25.00 liquidation preference per share, issued and outstanding, respectively 150 —
Stockholders’ equity
Common stock, $0.001 par value per share, 750,000,000 shares authorized, respectively, 273,532,761 and 280,066,433 shares issued and outstanding, respectively 0 0
Capital in excess of par value 9,124 9,199
Retained earnings (accumulated deficit) (4,125) (3,350)
Total stockholders’ equity 4,999 5,849
Total liabilities, preferred stock and stockholders’ equity 11,695 13,729
Net asset value per share of common stock at period end 18.28 20.89

Consolidated Statements of Cash Flows (Unaudited)

Description Nine months ended September 30, 2026 Nine months ended September 30, 2025
Cash flows from operating activities
Net increase (decrease) in net assets resulting from operations (402) 125
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Purchases of investments (1,431) (4,109)
Paid-in-kind interest (126) (169)
Proceeds from sales and repayments of investments 2,693 4,109
Net realized (gain) loss on investments 398 206
Net change in unrealized (appreciation) depreciation on investments 385 69
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts (11) 17
Realized loss on extinguishment of debt 2 3
Accretion of discount (16) (33)
Amortization of deferred financing costs and discount 15 16
Net change in unrealized (appreciation) depreciation on foreign currency translation (13) 100
(Increase) decrease in receivable for investments sold and repaid — 138
(Increase) decrease in income receivable 26 (20)
(Increase) decrease in prepaid expenses and other assets 3 7
Increase (decrease) in management fees payable (8) (2)
Increase (decrease) in subordinated income incentive fees payable (16) (2)
Increase (decrease) in administrative services expense payable 3 4
Increase (decrease) in interest payable (23) (38)
Increase (decrease) in other accrued expenses and liabilities (54) (24)
Net cash provided by (used in) operating activities 1,425 397
Cash flows from financing activities
Issuance of Cumulative Convertible Perpetual Preferred Stock, Series A 150 —
Repurchases of common stock (72) —
Distributions to common stockholders (252) (392)
Distributions to preferred stockholders (2) —
Borrowings under financing arrangements 2,998 6,545
Repayments of financing arrangements (4,268) (6,661)
Deferred financing costs paid (15) (30)
Net cash provided by (used in) financing activities (1,461) (538)
Effect of exchange rate changes on cash — —
Total increase (decrease) in cash, cash equivalents, restricted cash and foreign currency (36) (141)
Cash, cash equivalents, restricted cash and foreign currency at beginning of period 208 296
Cash, cash equivalents, restricted cash and foreign currency at end of period(1) 172 155
Supplemental information
Federal income taxes paid during the period 0 11
Interest paid during the period 313 376

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗